Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Prattes, J; Lackner, M; Eigl, S; Reischies, F; Raggam, RB; Koidl, C; Flick, H; Wurm, R; Palfner, M; Wölfler, A; Neumeister, P; Thornton, CR; Krause, R; Lass-Flörl, C; Hoenigl, M.
Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
Mycoses. 2015; 58(8):461-469
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Eigl Susanne
Flick Holger
Hönigl Martin
Koidl Christoph
Krause Robert
Neumeister Peter
Palfner Michael
Prattes Jürgen
Raggam Reinhard Bernd
Reischies Frederike Marie Josefine
Wölfler Albert
Wurm Robert

Dimensions Citations:

Plum Analytics:
We evaluated the performance of the Aspergillus-specific lateral-flow device (LFD) test for diagnosing invasive pulmonary aspergillosis (IPA) in patients with underlying haematological malignancies. Participating centres were the two Austrian University Hospitals of Graz and Innsbruck. LFD performance was evaluated with 95 bronchoalveolar lavage fluid (BALF) samples from 72 patients collected prospectively in Graz, and with 24 BALF bio bank samples from 23 patients (21 samples with probable IPA) in Innsbruck. Invasive fungal infections were classified according to the revised European Organization of Research and Treatment of Cancer/Mycoses Study Group criteria. Overall, 27 patients (30 samples) had probable IPA, 32 (43 samples) possible and 36 (46 samples) did not fulfil IPA criteria. The vast majority of patients - in particular those with probable IPA - received mould-active treatment before bronchoscopy. Sensitivity, specificity, positive predictive value and negative-predictive-value for probable IPA diagnosis using the BALF-LFD test were 71%, 76%, 35% and 94% for the Graz cohort. Sensitivity of the BALF-LFD test for probable IPA was 57% in Innsbruck bio bank samples. Our results indicate that the BALF-LFD-test provides fast results with moderate sensitivities in patients with underlying haematological malignancies. Similar to other diagnostic tests and biomarkers sensitivity of the test may be influenced by ongoing systemic mould-active treatment. © 2015 Blackwell Verlag GmbH.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Aspergillus - pathogenicity
Aspergillus -
Biomarkers -
Bronchoalveolar Lavage -
Bronchoalveolar Lavage Fluid - microbiology
Female -
Hematologic Neoplasms - complications
Hematologic Neoplasms - microbiology
Humans -
Immunologic Tests - methods
Immunologic Tests - standards
Immunologic Tests - statistics & numerical data
Invasive Pulmonary Aspergillosis - complications
Invasive Pulmonary Aspergillosis - diagnosis
Invasive Pulmonary Aspergillosis - immunology
Male -
Mannans - immunology
Middle Aged -
Point-of-Care Testing -
Prospective Studies -
Sensitivity and Specificity -

Find related publications in this database (Keywords)
Aspergillus lateral-flow device test
invasive aspergillosis
haematological malignancies
bronchoalveolar lavage
© Meduni Graz Impressum